Suchergebnisse - "Zingone, Fabiana"

PubPharm (9)

1

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection : an IG-IBD study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Bezzio, C. | Armuzzi, A. | Furfaro, F. | +69

2

Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak

enthalten in: Journal of clinical medicine | 2021

von Bertani, L. | Barberio, B. | Tricò, D. | +10

3

Effects of SARS-CoV-2 emergency measures on high-risk lesions detection : a multicentre cross-sectional study

enthalten in: Gut | 2021

von Furnari, M. | Eusebi, L. | Savarino, E. | +27

4

Increased COVID-19 Lockdown Burden in Italian Adults with Gastrointestinal Diseases

enthalten in: Nutrients | 2021

von Ruotolo, M. | Gagliardi, M. | Ciacci, C. | +5

5

Telemedicine in the COVID-19 era for Liver Transplant Recipients : an Italian lockdown area experience

enthalten in: Clinics and research in hepatology and gastroenterology | 2021

von Santonicola, A. | Zingone, F. | Camera, S. | +2

6

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic : Is It Really a Problem?

enthalten in: Gastroenterology | 2021

von Barberio, B. | Zingone, F. | Bertani, L. | +1

CommentOn: Gastroenterology. 2020 Oct;159(4):1592-1594.e1. - PMID 32574622

7

Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy : an international multicentre study

enthalten in: BMJ open gastroenterology | 2021

von Vanella, G. | Capurso, G. | Burti, C. | +44

8

Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy

enthalten in: Clinical and experimental gastroenterology | 2021

von Ciacci, C. | Gagliardi, M. | Siniscalchi, M. | +4

9

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection : an IG‐IBD study

enthalten in: Alimentary Pharmacology & Therapeutics | 2021

von Bezzio, C. | Armuzzi, A. | Furfaro, F. | +22

1
[1]